Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Altmedical
Sarasota, Florida, USAaltmed.co ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
Altmed (Alternative Medical Enterprises) is a research-oriented medical cannabis company that focuses on the development and commercialization of pharmaceutical-grade cannabinoid products. Founded in 2014 by pharmaceutical industry veterans, the company applies rigorous scientific standards to the cultivation, extraction, and formulation of its therapies. Its flagship brand, MÜV, features a diverse portfolio of delivery methods, including patented transdermal patches, metered-dose inhalers, and various topical and oral formulations. Altmed was acquired by Verano Holdings in 2021, merging its operations to create one of the largest multi-state operators in the United States.
- Therapeutic areas
- PsychiatryNeurologyOncology
- Modalities
- Small moleculeCannabinoidsPlant-based therapy
- Industry
- Biotech
Beyond the preview
Go deeper on Altmedical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Altmedical.